SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006862
Filing Date
2021-05-12
Accepted
2021-05-12 07:30:46
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20210331x10q.htm   iXBRL 10-Q 1007122
2 EX-5.1 zyne-20210331xex5d1.htm EX-5.1 14362
3 EX-10.1 zyne-20210331xex10d1.htm EX-10.1 330429
4 EX-31.1 zyne-20210331xex31d1.htm EX-31.1 11629
5 EX-31.2 zyne-20210331xex31d2.htm EX-31.2 11366
6 EX-32.1 zyne-20210331xex32d1.htm EX-32.1 6085
7 EX-32.2 zyne-20210331xex32d2.htm EX-32.2 6106
8 GRAPHIC zyne-20210331xex5d1003.jpg GRAPHIC 865
9 GRAPHIC zyne-20210331xex5d1002.jpg GRAPHIC 5854
  Complete submission text file 0001558370-21-006862.txt   5305487

Data Files

Seq Description Document Type Size
10 EX-101.SCH zyne-20210331.xsd EX-101.SCH 36361
11 EX-101.CAL zyne-20210331_cal.xml EX-101.CAL 43007
12 EX-101.DEF zyne-20210331_def.xml EX-101.DEF 129759
13 EX-101.LAB zyne-20210331_lab.xml EX-101.LAB 317531
14 EX-101.PRE zyne-20210331_pre.xml EX-101.PRE 263542
15 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20210331x10q_htm.xml XML 916650
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 21913454
SIC: 2834 Pharmaceutical Preparations